CFY Biomedicals Inc.
This article was originally published in Start Up
Executive Summary
San Diego-based CFY Biomedicals Inc. believes it has the technological wherewithal to create a cure and/or preventive for the common cold. It's betting on antibody-based products that block the receptor which most forms of human rhinovirus (HRV) use to enter and infect nasal epithelial cells.